RECURRENT EPITHELIAL OVARIAN CANCER
Clinical trials for RECURRENT EPITHELIAL OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT EPITHELIAL OVARIAN CANCER trials appear
Sign up with your email to follow new studies for RECURRENT EPITHELIAL OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a Patient's own immune cells be supercharged to fight ovarian cancer?
⭐️ CURE ⭐️ Not yet recruitingThis trial is testing whether a personalized cell therapy can help women with ovarian cancer that has returned. Doctors will remove a tumor, extract immune cells called tumor-infiltrating lymphocytes (TILs), and boost them in the lab before infusing them back into the patient. Af…
Matched conditions: RECURRENT EPITHELIAL OVARIAN CANCER
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: ⭐️ CURE ⭐️
Last updated Jul 24, 2026 00:00 UTC
-
New triple therapy aims to stall return of ovarian cancer
Disease control Not yet recruitingThis study tests a combination of three drugs (Benmelstobart, Anlotinib, and low-dose Cyclophosphamide) in 40 women whose ovarian, fallopian tube, or peritoneal cancer has come back. The goal is to see if this mix can keep the cancer from growing for longer. Participants must be …
Matched conditions: RECURRENT EPITHELIAL OVARIAN CANCER
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC